Ruth de Tute

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for ...

CLL-therapie gestuurd door MRD: overzicht